Time To Efficacy and Onset Of Action Of Linezolid

Pfizer

Status and phase: Completed; Phase 4

Conditions: Skin and Connective Tissue Diseases; Gram-Positive Bacterial Infections

Treatments: Drug: linezolid

Study type: Interventional

Funder types: Industry

Identifiers

NCT00147511

OXAA-0026-162

Details and patient eligibility

About

To assess the onset of action of linezolid

Enrollment: 118 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• suspected grampositive infection
• fever > 38 C

Exclusion criteria

• Infections to be treated successfully by surgical procedures

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)